Marianne Williamson

The statement by @drpaolandmd and the subsequent response by another user engage in a discussion about the FDA's decision-making process and the influence of pharmaceutical companies, which are public issues. Therefore, it constitutes public discourse.

1. Principle 1:

   I will strive to do no harm with my words and actions.

   The statement by @drpaolandmd and the response do not directly cause harm, but the tone is dismissive and could be seen as undermining the credibility of the individuals involved. This is a minor violation of striving to do no harm. [-1]
2. Principle 2:

   I will respect the privacy and dignity of others and will not engage in cyberbullying, harassment, or hate speech.

   The response to @drpaolandmd's statement questions their naivety and indirectly their professional competence, which can be seen as disrespectful and bordering on harassment. This is a moderate violation of respecting the privacy and dignity of others. [-2]
3. Principle 3:

   I will use my words and actions to promote understanding, empathy, and compassion.

   The statements do not promote understanding, empathy, or compassion. Instead, they seem to escalate the disagreement. This is a minor violation of promoting understanding and empathy. [-1]
4. Principle 4:

   I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.

   The response to @drpaolandmd's statement is a personal attack rather than constructive criticism. This is a significant violation of engaging in constructive dialogue and avoiding personal attacks. [-2]